Partnering Opportunities

Hepion is advancing first-in-class liquid biopsy tests for hepatocellular carcinoma/HCC (liver cancer), with potential applications in other solid tumors. The company is on a clear path toward integrating diagnostics and therapeutics in a closed loop theranostics model. Our flexible business models, strong IP position, and public company structure create multiple pathways to value creation for the right partners. To initiate discussions, please contact us or complete the form below.